Table 1.
Characteristics at enrollment survey among participants who have completed all regimen doses.
| All Participants N = 6966 |
Pfizer N = 3486 |
Moderna N = 2857 |
J&J N = 623 |
|
|---|---|---|---|---|
| Age in years (N) | 6966 | 3486 | 2857 | 623 |
| Mean (SD) | 48.3 (15.64) | 47.0 (15.62) | 50.1 (15.69) | 47.1 (14.78) |
| Median [IQR] | 48 [35.0,62.0] | 45 [34.0,61.0] | 51 [36.0,64.0] | 48 [35.0,60.0] |
| Missing | 0 | 0 | 0 | 0 |
| Age Group (years) | 6966 | 3486 | 2857 | 623 |
| 18–29 | 781 (11.2) | 433 (12.4) | 260 (9.1) | 88 (14.1) |
| 30–39 | 1768 (25.4) | 966 (27.7) | 678 (23.7) | 124 (19.9) |
| 40–49 | 1067 (15.3) | 551 (15.8) | 402 (14.1) | 114 (18.3) |
| 50–59 | 1241 (17.8) | 581 (16.7) | 519 (18.2) | 141 (22.6) |
| >=60 | 2109 (30.3) | 955 (27.4) | 998 (34.9) | 156 (25.0) |
| Missing | 0 | 0 | 0 | 0 |
| Gender | 6966 | 3486 | 2857 | 623 |
| Female | 5821 (83.6) | 2913 (83.6) | 2404 (84.1) | 504 (80.9) |
| Male | 971 (13.9) | 483 (13.9) | 392 (13.7) | 96 (15.4) |
| Transgender | 72 (1.0) | 33 (0.9) | 27 (0.9) | 12 (1.9) |
| Other | 82 (1.2) | 47 (1.3) | 27 (0.9) | 8 (1.3) |
| Not Disclosed | 20 (0.3) | 10 (0.3) | 7 (0.2) | 3 (0.5) |
| Missing | 0 | 0 | 0 | 0 |
| Pregnant | 5821 | 2913 | 2404 | 504 |
| Yes | 1121 (19.3) | 662 (22.7) | 398 (16.6) | 61 (12.1) |
| Missing | 0 | 0 | 0 | 0 |
| Education | 6949 | 3477 | 2850 | 622 |
| High school or less | 624 (9.0) | 296 (8.5) | 248 (8.7) | 80 (12.9) |
| Some college | 2056 (29.6) | 973 (28.0) | 855 (30.0) | 228 (36.7) |
| 4-yr college degree | 1813 (26.1) | 959 (27.6) | 701 (24.6) | 153 (24.6) |
| >4yr college degree | 2456 (35.3) | 1249 (35.9) | 1046 (36.7) | 161 (25.9) |
| Missing | 17 | 9 | 7 | 1 |
| Race | 6957 | 3481 | 2856 | 620 |
| Black or African American | 88 (1.3) | 52 (1.5) | 31 (1.1) | 5 (0.8) |
| White | 6320 (90.8) | 3140 (90.2) | 2614 (91.5) | 566 (91.3) |
| Other* | 549 (7.9) | 289 (8.3) | 211 (7.4) | 49 (7.9) |
| Missing | 9 | 5 | 1 | 3 |
| Ethnicity | 6949 | 3474 | 2853 | 622 |
| Hispanic or Latino | 392 (5.6) | 203 (5.8) | 157 (5.5) | 32 (5.1) |
| Missing | 17 | 12 | 4 | 1 |
| BMI | 6626 | 3319 | 2719 | 588 |
| Underweight or Normal weight (15.0 - <25.0) | 1778 (26.8) | 922 (27.8) | 703 (25.9) | 153 (26.0) |
| Overweight (25.0- <30.0) | 1857 (28.0) | 913 (27.5) | 787 (28.9) | 157 (26.7) |
| Obese (30.0 - ≤ 40.0) | 2215 (33.4) | 1113 (33.5) | 913 (33.6) | 189 (32.1) |
| Severe Obesity (>40.0) | 776 (11.7) | 371 (11.2) | 316 (11.6) | 89 (15.1) |
| Missing | 340 | 167 | 138 | 35 |
| Smoker | 6484 | 3256 | 2647 | 581 |
| Yes | 611 (9.4) | 275 (8.4) | 257 (9.7) | 79 (13.6) |
| Missing | 482 | 230 | 210 | 42 |
| Vaccinated for Influenza | 6677 | 3343 | 2738 | 596 |
| Yes | 4974 (74.5) | 2514 (75.2) | 2111 (77.1) | 349 (58.6) |
| Missing | 289 | 143 | 119 | 27 |
| Medical Conditions | 6755 | 3383 | 2768 | 604 |
| Anxiety | 2656 (39.3) | 1348 (39.8) | 1062 (38.4) | 246 (40.7) |
| Autoimmune disease | 843 (12.5) | 406 (12.0) | 359 (13.0) | 78 (12.9) |
| Blood disorder | 173 (2.6) | 87 (2.6) | 75 (2.7) | 11 (1.8) |
| Cardiovascular disease | 407 (6.0) | 175 (5.2) | 186 (6.7) | 46 (7.6) |
| Depression | 2190 (32.4) | 1103 (32.6) | 891 (32.2) | 196 (32.5) |
| Diabetes | 678 (10.0) | 319 (9.4) | 304 (11.0) | 55 (9.1) |
| Hypertension | 1583 (23.4) | 733 (21.7) | 715 (25.8) | 135 (22.4) |
| Insomnia or trouble sleeping | 2074 (30.7) | 1039 (30.7) | 853 (30.8) | 182 (30.1) |
| Kidney disease | 233 (3.4) | 113 (3.3) | 96 (3.5) | 24 (4.0) |
| Lung disease | 671 (9.9) | 307 (9.1) | 301 (10.9) | 63 (10.4) |
| Organ transplant | 18 (0.3) | 12 (0.4) | 6 (0.2) | 0 |
| Missing | 211 | 103 | 89 | 19 |
| On Treatment for Cancer? | 6745 | 3377 | 2764 | 604 |
| Yes | 76 (1.1) | 44 (1.3) | 25 (0.9) | 7 (1.2) |
| Missing | 221 | 109 | 93 | 19 |
| Sub-study incentive received** | 6966 | 3486 | 2857 | 623 |
| Yes | 110 (1.6) | 53 (1.5) | 37 (1.3) | 20 (3.2) |
| Missing | 0 | 0 | 0 | 0 |
*
The race category of other includes: 24 American Indians, 112 Asians, 4 Hawaiian or Pacific Islander, 249 who selected multiple races and 160 who selected 'other'.
**
110 enrolled in a sub-study that required additional data collection. These participants were compensated for their time participating in the sub-study.